Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9393257 TALEN-based gene correction

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
February 28, 2014
Date of Patent
July 19, 2016
Patent Application Number
14193037
Patent Citations Received
‌
US Patent 12091681 Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
0
‌
US Patent 11925664 Intracellular genomic transplant and methods of therapy
0
‌
US Patent 11965012 Compositions and methods for TCR reprogramming using fusion proteins
0
‌
US Patent 11981892 Compositions and methods for improved gene editing
0
‌
US Patent 11753677 Methods for barcoding macromolecules in individual cells
‌
US Patent 11851491 Compositions and methods for TCR reprogramming using fusion proteins
0
‌
US Patent 11873487 Compositions and methods for improved gene editing
0
‌
US Patent 11903966 Intracellular genomic transplant and methods of therapy
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9393257
Patent Primary Examiner
‌
Scott Long

Find more entities like US Patent 9393257 TALEN-based gene correction

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.